MPP+로 유도된 SH-SY5Y신경세포 사멸에 대한 고분자성분제거 봉독약침액의 신경보호 효과 연구
Neuroprotective Effects of Bee Venom, which Removes High Molecular Elements against MPP+-induced Human Neuroblastoma SH-SY5Y Cell Death
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives : The neuroprotective effects of bee venom (BV) have been demonstrated in many studies, but bee venom has many side effects. So we used sweet bee venom (SBV), which has high molecular elements removed to reduce the side effects. I examined the neuroprotective effect of sweet bee venom in 1-methyl-4-phenylpyridine (MPP+)-induced human neuroblastoma SH-SY5Y cells. Methods : To observe the possible toxicity of SBV itself, SH-SY5Y cells were treated with SBV in various concentrations for 3 h and MPP+ in concentrations (1 and 5mM) for 24h. To investigate the protective effect of SBV against MPP+ toxicity, SH-SY5Y cells were pretreated with vehicle or nontoxic concentrations of SBV for 3h and the cells were not washed, followed by incubation with respective concentrations of SBV and 1 mM MPP+ for 24h. To investigate the protective effect of SBV against MPP+ toxicity, SH-SY5Y cells were pretreated with vehicle or nontoxic concentrations of SBV for 3h and the cells were not washed, followed by incubation with respective of SBV(0.5%), 1 mM MPP+, 5uM AKT inhibitor(LY984002) and 10uM ERK inhibitor(PD98059) for 24 h. The protective effect was measured by cell viability assay. To investigate the degree of apoptosis, caspase-3 enzyme activity was measured in control, MPP+, SBV+MPP+. Results : SBV (0.5%) pretreatment protected the SH-SY5Y cells against MPP+-induced apoptotic cell death. The cell viability was higher in the SH-SY5Y cells that were pretreated with vehicle or nontoxic concentrations of SBV than those not pretreated. The caspase-3 activity was lower in the pretreated groups than these not pretreated. ERK and AKT enzymes have a role in the neuroprotective effects of the sweet bee venom. Conclusions : The results demonstrate that SBV has a protective effect on dopaminergic neurons against MPP+ toxicity. This data suggest that SBV could be a potential therapeutic tool for neurodegenerative diseases such as Parkinson's disease(PD).
Abstract
Objectives : The neuroprotective effects of bee venom (BV) have been demonstrated in many studies, but bee venom has many side effects. So we used sweet bee venom (SBV), which has high molecular elements removed to reduce the side effects. I examined the neuroprotective effect of sweet bee venom in 1-methyl-4-phenylpyridine (MPP+)-induced human neuroblastoma SH-SY5Y cells. Methods : To observe the possible toxicity of SBV itself, SH-SY5Y cells were treated with SBV in various concentrations for 3 h and MPP+ in concentrations (1 and 5mM) for 24h. To investigate the protective effect of SBV against MPP+ toxicity, SH-SY5Y cells were pretreated with vehicle or nontoxic concentrations of SBV for 3h and the cells were not washed, followed by incubation with respective concentrations of SBV and 1 mM MPP+ for 24h. To investigate the protective effect of SBV against MPP+ toxicity, SH-SY5Y cells were pretreated with vehicle or nontoxic concentrations of SBV for 3h and the cells were not washed, followed by incubation with respective of SBV(0.5%), 1 mM MPP+, 5uM AKT inhibitor(LY984002) and 10uM ERK inhibitor(PD98059) for 24 h. The protective effect was measured by cell viability assay. To investigate the degree of apoptosis, caspase-3 enzyme activity was measured in control, MPP+, SBV+MPP+. Results : SBV (0.5%) pretreatment protected the SH-SY5Y cells against MPP+-induced apoptotic cell death. The cell viability was higher in the SH-SY5Y cells that were pretreated with vehicle or nontoxic concentrations of SBV than those not pretreated. The caspase-3 activity was lower in the pretreated groups than these not pretreated. ERK and AKT enzymes have a role in the neuroprotective effects of the sweet bee venom. Conclusions : The results demonstrate that SBV has a protective effect on dopaminergic neurons against MPP+ toxicity. This data suggest that SBV could be a potential therapeutic tool for neurodegenerative diseases such as Parkinson's disease(PD).
참고문헌 (37)
- 이광우, "임상신경학", pp.622~629 (2002), 법문사
- Gelb DJ, "Diagnostic criteria for Parkinson disease", Arch Neurol, 56(1), pp.33~39 (1999)
- Shastry BS, "Parkinson disease:etiology, pathogenesis and future of gene therapy", Neurosci Res, 41(1), pp.5~12 (2001)
- 이애영, "파킨슨병과 파킨슨증후군", pp.1~2 (2000), 군자출판사
- Boris Ferger, "Genetic ablation of tumor necrosis factor-alpha(TNF-α) and pharmacolofical ingibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum", Journal of Neurochemistry, 89, pp.822~833 (2004)
- Yacoubian TA, "Targets for neuroprotection in Parkinson's disease", Biochim Biophys Acta., 1792(7), pp.676~687 (2008)
- Ramachandran B, "Differential expression of transporters for norepinephrine and glutamate in wild type, variant, and WNT1 -expressing PC12 cells", J Biol Chem., 268(32), pp.23891~23897 (1993)
- Lee P, "15,16-dihydrotanshinone I suppresses the activation of BV-2 Cell, a murine microglia cell line, by lipopolysaccharide", Neurochem Int., 48(1), pp.60~66 (2006)
- 대한약침학회, "약침요법 시술 지침서", pp.133~135 (1999), 대한약침학회
- Yoo Jin Hwang, "Clinical research of Bee-venom Acupuncture effects on Rheumatoid arthritis", The Journal of Korean Acupuncture & Moxibustion Society, 18(5), pp.33~41 (2001)
- 배은정, "蜂毒藥鍼竝行治療한 腰椎幹板脫出症患者의 臨床考察", 대한침구학회지, 19(1), pp.54~64 (2002), 대한침구학회
- Hwang YJ, "Clinical Study of Anaphylaxis on Bee-Venom Acupuncture", The Journal of Korean Acupuncture & Moxibustion Society, 17(4), pp.149~159 (2000)
- 윤현민, "봉약침요법으로 발생한 Anaphylaxis에 대한 임상보고", 대한침구의학회지, 22(4), pp.179~188 (2005), 대한침구의학회
- 권기록, "Sweet BV의 성분분석과 항체역가 및 allergy 반응에 대한 임상적 연구", 대한약침학회지, 9(2), pp.79~86 (2006), 대한약침학회
- 이진선, "봉약침(Bee Venom)과 Sweet Bee Venom의 Allergy 반응에 대한 비교연구", 대한약침학회지, 9(3), pp.61~77 (2006), 대한약침학회
- 김성철, "동일 농도(0.1㎎", ㎖)의 Sweet Bee Venom과 봉약침의 퇴행성 슬관절염에 대한 임상연구, 2008, pp.11(1), 31~40[DOI]
- 김재홍, "만성요통환자에 대한 Bee Venom과 Sweet Bee Venom의 치료효능 비교 연구", 대한약침학회지, 11(4), pp.15~24 (2008), 대한약침학회
- 육태한, "Sweet Bee Venom과 Bee Venom이 심박변이도(HRV)에 미치는 영향", 대한약침학회지, 11(1), pp.41~54 (2008), 대한약침학회
- 안중철, "봉독과 Sweet Bee Venom의 항균 및 항산화능 비교연구", 대한약침학회지, 9(3), pp.97~104 (2006), 대한약침학회
- Kazuhiro Nakaso, "Caffeine activates the PI3K", Akt pathway and prevents apoptotic cell death in a Parkinson’s disease model of SH-SY5Y cells, 2008, pp.432(2), 146~150
- McGeer PL, "Glial reactions in Parkinson's disease", Mov Disord, 23(4), pp.474~483 (2008)
- Rock RB, "Microglia as a pharmacological target in infectious and inflammatory diseases of the brain", J Neuroimmune Pharmacol, 1(2), pp.117~126 (2006)
- Wilms H, "Imflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications", Curr Pharm Des., 13(18), pp.1925~1928 (2007)
- Van Kampen J, "Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson’s disease", Exp Neurol., 184(1), pp.521~529 (2003)
- Cao F, "Experimental study on inhibition of neuronal toxical effect of levodopa by ginkgo biloba extract on Parkinson disease in rats", J Huazhong Univ Sci Technolog Med Sci., 23(2), pp.151~153 (2003)
- Ramassamy C, "Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets", Eur J Pharmacol., 545(1), pp.51~64 (2006)
- 이상훈, "MPTP 유발 파킨슨 병 동물 모델에서의 신수혈(BL23) 봉독약침의 항염증 효과", 대한침구학회지, 26(4), pp.49~58 (2009)
- 권기록, "봉침에 대한 고찰", 대한 침구학회지, 11(1), pp.160~ (1994)
- 인창식, "봉독요법에 대한 한의학 최초의 문헌기록: 마왕퇴의서의 봉독요법 2례", 대한침구학회지, 15(1), pp.143~ (1998)
- 권기록, "Sweet BV의 함량분석과 시술 부위별 LD50관찰", 대한약침학회지, 10(2), pp.81~86 (2007), 대한약침학회
- 정영석, "1-methyl-4-phenylpyridinium(MPP+)로 유도된 파킨슨병의 세포 손상에 대한 황백의 신경세포 보호효과", 대한한방내과학회지, 30(1), pp.51~63 (2009), 대한한방내과학회
- Zhou J, "Huperzine A attenuates apoptosis and mitochondria-dependent caspase-3 in rat cortical neurons", FEBS Lett, 526, pp.21~25 (2002)
- Grammatopoulos TN, "Angiotensin II attenuates chemical hypoxia-induced caspase-3 activation in primary cortical neuronal cultures", Brain Res Bull., 62, pp.297~303 (2004)
- Chang SH, "Studies on the mechanisms and kinetics of apoptosisinduced by microinjection of cytochrome c in rat kidney tubule eputhelial cells(NRK-52E)", Am J Pathol, 156, pp.637~649 (2000)
- Mattson MP, "Anti-apoptotic actions of cycloheximide: blockade of programmed cell death or induction of programmed cell life?", Apoptosis, 2, pp.257~264 (1997)
- Dudek H, "Regulation of neuronal survival by the serine-threonine protein kinase Akt", Science, 275, pp.661~665 (1997)
- Stanciu M, "Prolonged nuclear retention of activated ERK promotes cell death generated by oxidative toxicity or proteasome inhibition in a neuronal cell line", J Biol Chem., 277, pp.4010~4017 (2002)
